Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic

Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic.

It can be given every 2 weeks in a clinic.

This could help patients who have trouble taking their meds...and possibly decrease the chance of hospitalization for relapse.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote